{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-23-182843","form_type":"8-K","ticker":"XAGE","cik":"0001842939","company_name":"Longevity Health Holdings, Inc.","filed_at":"2023-07-06T23:59:59+00:00","discovered_at":"2026-05-14T18:03:35.676870+00:00","generated_at":"2026-06-13T12:09:27.776959+00:00","sec_items":["8.01","9.01"],"event_type":"m_and_a","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Alpha Healthcare provides Carmell merger update; LOI for commercial stage allograft company with $50M revenue","bullets":["Shareholder vote for Carmell merger scheduled July 11, 2023; redemption deadline July 7.","Non-binding LOI to acquire a commercial stage allograft company with ~$50M TTM revenue and ~$5M EBITDA.","Deal terms: $65M initial equity ($8M cash + $57M stock) plus up to $75M milestone payments (12% cash, 88% stock); 12-month lockup.","Carmell's pipeline: Phase 2 tibia fracture trial (Fast Track), FDA agreed HEAL II start; foot/ankle fusion program.","Post-merger ticker CTCX; plan to build leading player in aesthetics and orthopedics through roll-ups."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-23-182843","json":"https://secwatch.observer/filing/0001193125-23-182843.json","markdown":"https://secwatch.observer/filing/0001193125-23-182843.md","text":"https://secwatch.observer/filing/0001193125-23-182843.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1842939/000119312523182843/0001193125-23-182843-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1842939/000119312523182843/d492441d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-13T12:09:27.776959+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}